$PVCT.OB: Provectus Presents Nonclinical Data on Antitumor Immune Response to PV-10 Immuno-Chemoablation

Provectus issued a PR today about Craig et al.'s poster presentation at SITC 27th Annual Meeting. I have a lot of blogging to do on this topic this week. The time to progression graphs caught my eye at the outset.